CapsoVision, Inc Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CapsoVision, Inc (CV) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $5.91 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-26
- CapsoVision, Inc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $5.91M, a 25.79% increase from fiscal 2024.
- CapsoVision, Inc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $4.70M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $5.91M 10-K · filed 2026-03-26 |
| 2024-12-31 | $4.70M 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |